{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T09:24:05Z","timestamp":1762161845234,"version":"3.41.2"},"reference-count":9,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaacap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Child & Adolescent Psychiatry"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.jaac.2024.07.913","type":"journal-article","created":{"date-parts":[[2024,7,30]],"date-time":"2024-07-30T21:10:36Z","timestamp":1722373836000},"page":"89-91","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Transdermal Asenapine for Agitation and Irritability in a Child With Complete Intravenous Dependence"],"prefix":"10.1016","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-6395-9010","authenticated-orcid":false,"given":"Julia N.","family":"Stimpfl","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1893-996X","authenticated-orcid":false,"given":"Katherine C.","family":"Soe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaac.2024.07.913_bib1","doi-asserted-by":"crossref","DOI":"10.1177\/20451253211035269","article-title":"Asenapine: an atypical antipsychotic\u00a0with\u00a0atypical formulations","volume":"11","author":"Musselman","year":"2021","journal-title":"Ther Adv Psychopharmacol"},{"year":"2019","series-title":"Secuado\u00ae (asenapine) transdermal system [package insert]","key":"10.1016\/j.jaac.2024.07.913_bib2"},{"issue":"5","key":"10.1016\/j.jaac.2024.07.913_bib3","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1089\/cap.2015.0027","article-title":"Safety and efficacy from an 8 week double-blind trial and a 26 week open-label extension of asenapine in adolescents with schizophrenia","volume":"25","author":"Findling","year":"2015","journal-title":"J\u00a0Child Adolesc Psychopharmacol"},{"issue":"12","key":"10.1016\/j.jaac.2024.07.913_bib4","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/j.jaac.2015.09.007","article-title":"Asenapine for the acute treatment of\u00a0pediatric manic or mixed episode of bipolar I disorder","volume":"54","author":"Findling","year":"2015","journal-title":"J\u00a0Am Acad Child Adolesc\u00a0Psychiatry"},{"key":"10.1016\/j.jaac.2024.07.913_bib5","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.2147\/NDT.S165743","article-title":"Post hoc analyses of asenapine treatment in pediatric patients with bipolar I disorder: efficacy related to mixed or manic episode, stage of illness, and body weight","volume":"14","author":"Findling","year":"2018","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"2","key":"10.1016\/j.jaac.2024.07.913_bib6","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s40272-017-0274-9","article-title":"Asenapine treatment in pediatric patients with bipolar I disorder or schizophrenia: a review","volume":"20","author":"Stepanova","year":"2018","journal-title":"Pediatr Drugs"},{"key":"10.1016\/j.jaac.2024.07.913_bib7","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.2147\/DDDT.S171475","article-title":"Asenapine pharmacokinetics and tolerability in a pediatric population","volume":"12","author":"Dogterom","year":"2018","journal-title":"Drug Des Dev Ther"},{"issue":"6","key":"10.1016\/j.jaac.2024.07.913_bib8","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1007\/s00213-013-3068-y","article-title":"Atypical antipsychotics in the treatment of children and adolescents with pervasive developmental disorders","volume":"231","author":"Politte","year":"2014","journal-title":"Psychopharmacology"},{"issue":"6","key":"10.1016\/j.jaac.2024.07.913_bib9","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1007\/s11605-009-1151-9","article-title":"The impact of intestinal failure on oral drug absorption: a review","volume":"14","author":"Ward","year":"2010","journal-title":"J\u00a0Gastrointest Surg"}],"container-title":["Journal of the American Academy of Child & Adolescent Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890856724013091?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890856724013091?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T19:00:53Z","timestamp":1753729253000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0890856724013091"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":9,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S0890856724013091"],"URL":"https:\/\/doi.org\/10.1016\/j.jaac.2024.07.913","relation":{},"ISSN":["0890-8567"],"issn-type":[{"type":"print","value":"0890-8567"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Transdermal Asenapine for Agitation and Irritability in a Child With Complete Intravenous Dependence","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Child & Adolescent Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaac.2024.07.913","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a92024 American Academy of Child and Adolescent Psychiatry","name":"copyright","label":"Copyright"}]}}